Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Receivables (2016 - 2023)

Summit Therapeutics filings provide 10 years of Change in Receivables readings, the most recent being -$3000.0 for Q3 2023.

  • Quarterly Change in Receivables rose 99.76% to -$3000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $0.0 through Dec 2024, up 100.0% year-over-year, with the annual reading at -$359000.0 for FY2023, 63.18% up from the prior year.
  • Change in Receivables hit -$3000.0 in Q3 2023 for Summit Therapeutics, up from -$6000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $8.1 million in Q4 2019 and bottomed at -$6.3 million in Q3 2019.
  • Average Change in Receivables over 5 years is $639739.9, with a median of $18028.1 recorded in 2019.
  • The largest annual shift saw Change in Receivables skyrocketed 3953.4% in 2020 before it plummeted 499.12% in 2022.
  • Summit Therapeutics' Change in Receivables stood at $8.1 million in 2019, then plummeted by 145.46% to -$3.7 million in 2020, then soared by 74.76% to -$932000.0 in 2021, then surged by 251.5% to $1.4 million in 2022, then plummeted by 100.21% to -$3000.0 in 2023.
  • Per Business Quant, the three most recent readings for SMMT's Change in Receivables are -$3000.0 (Q3 2023), -$6000.0 (Q2 2023), and -$350000.0 (Q1 2023).